Autolus Therapeutics AUTL
NASDAQ AUTL
$1.24 -0.09 (-6.44%)
At close: Nov 11, 2026 · 4:00 PM EST

Autolus Therapeutics (AUTL) Return on Sales [ROS] (2017 - 2026)

Updated

Autolus Therapeutics (AUTL) recorded Return on Sales [ROS] of -95.95% in Q2 2026, up 196.63 percentage points from -292.58% a year earlier.

Analysis

Autolus Therapeutics (AUTL) Return on Sales [ROS] (2017 - 2026) Analysis & Trends

On a TTM basis, Autolus Therapeutics' Return on Sales [ROS] came in at -222.26% as of Jun 30, 2026, up 680.38 percentage points year-over-year; for FY2025, it came in at -358.87%, up 2026.76 percentage points from FY2024.

  • Annual Return on Sales [ROS] has a five-year change of +9445.50 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Sales [ROS] came in at -2385.63% in FY2024 (+8197.47 pp), -10583.10% in FY2023 (-8328.25 pp), -2254.84% in FY2022 (+3798.81 pp) and -6053.65% in FY2021 (+3750.73 pp).
  • The Q2 2026 figure is the highest quarterly Return on Sales [ROS] in data going back to Q1 2018.
  • On a year-over-year basis, Return on Sales [ROS] rose in five of the last seven quarters, with an average year-over-year change of +3131.88 percentage points.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 261301.65 percentage points in Q4 2025, against a drop of 251016.90 percentage points in Q4 2024 at the low end.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Autolus Therapeutics 468.91 Mn -511.27 Mn 23.31 Mn -105.57%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -105.57%
Jun 30, 2026 -95.95%
Mar 31, 2026 -226.99%
Dec 31, 2025 -298.35%
Sep 30, 2025 -337.93%
Jun 30, 2025 -292.58%
Mar 31, 2025 -726.34%
Dec 31, 2024 -261,600.00%
Mar 31, 2024 -384.07%
Jun 30, 2023 -1,770.26%
Mar 31, 2023 -3,030.03%
Dec 31, 2022 -304.58%
Sep 30, 2022 -1,576.49%
Jun 30, 2022 -23,832.30%
Mar 31, 2022 -21,798.80%
Dec 31, 2021 -12,833.33%
Sep 30, 2021 -17,099.58%
Jun 30, 2021 -2,293.19%
Mar 31, 2021 -14,822.30%
Dec 31, 2020 -23,200.98%
API Access

Autolus Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=AUTL&period=max&api_key=YOUR_API_KEY